Mon. December 01, 2008
-
CBC.ca
December 1, 2008
David, who doesn't want his last name used, deals with a host of other health complications, including double pneumonia, non-Hodgkin's lymphoma and atrial ...
GoErie.com
December 1, 2008
He is also in remission from
non-Hodgkin's lymphoma, and has arthritis in his lower back. About 75 million
Americans like Ronzitti suffer from chronic pain, ...
Boston Globe
December 1, 2008
Andruzzi, who won three rings with the Pats, was diagnosed 18 months ago with Burkitt's
lymphoma, an aggressive form of
non-Hodgkin lymphoma. ...
MarketWatch
December 1, 2008
The FIT trial demonstrated that when used as a first-line consolidation therapy for patients with follicular non-Hodgkin's lymphoma, Zevalin significantly ...
MarketWatch
November 26, 2008
non-Hodgkin's lymphoma (NHL) is caused by the abnormal proliferation of white blood cells and normally spreads through the lymphatic system, ...
MedPage Today
November 18, 2008
...
cervical cancer, and
non-Hodgkin's lymphoma -- but little is known about the risks of other forms of malignancy among those infected with the virus. ...
MarketWatch
November 10, 2008
The EXTEND clinical trial is a phase III single-agent trial of pixantrone for patients with relapsed, aggressive non-Hodgkin's lymphoma who received two or ...
MarketWatch
November 9, 2008
non-Hodgkin's lymphoma (NHL) is caused by the abnormal proliferation of white blood cells and normally spreads through the lymphatic system, ...
The Virtual Medical Centre
November 6, 2008
A new combination of anti-
cancer drugs, when integrated into an existing treatment for
non-Hodgkin lymphoma, causes reduced risk for side effects in ...
Drug Topics Magazine
November 4, 2008
"Continued epidemiologic research is critically needed to piece together the puzzle of non-Hodgkin lymphoma etiology, and the report by de Jong et al ...
Newsday
November 4, 2008
... against Republican incumbent Randy Kuhl Jr. The 49-year-old Democrat retired from the
navy after he was stricken with
non-Hodgkin's lymphoma in 1997. ...
Trading Markets (press release)
November 4, 2008
Approval of Treanda for non-Hodgkin's lymphoma (NHL) followed the results of a Phase III trial in which Treanda monotherapy was administered to 100 patients ...
Science Daily (press release)
November 4, 2008
"A striking finding in our study is the approximate twenty-fold increased risk of non-Hodgkin's lymphoma among liver transplant patients relative to the ...
Cancer Consultants
November 4, 2008
... B-cell non-Hodgkin's lymphoma that has progressed during or within six months of therapy with Rituxan® (rituximab) or Rituxan-containing regimens. ...
Prescribing Reference
November 3, 2008
The FDA has approved Treanda (bendamustine HCl injection, from Cephalon) for the treatment of indolent B-cell non-Hodgkin's lymphoma (NHL) that has ...
DG News
November 3, 2008
"Because most patients with indolent non-Hodgkin's lymphoma eventually become resistant to existing treatments, new treatment options like [bendamustine ...
San Diego Union Tribune
November 2, 2008
Cephalon Inc. received federal approval to sell its chemotherapy drug Treanda for treatment of patients with a type of non-Hodgkin's lymphoma. ...
Telegraph.co.uk
November 2, 2008
Patients in the same area were three times as likely to receive drug Rituximab, for
non-Hodgkin lymphoma, as those in the East of
England, while spending on ...
Tehran Times
October 31, 2008
In women, the highest increases were in breast and bladder
cancer, and non-
Hodgkin's lymphoma. On hearing that DU had been used in the Persain
gulf in 1991 ...
Reuters
October 31, 2008
The latest approval applies to Treanda for the treatment of patients with indolent B-cell non-Hodgkin's lymphoma (NHL) that has progressed despite treatment ...
MarketWatch
October 29, 2008
... from various B-cell related blood
cancers including: chronic lymphocytic leukemia; mantle cell
lymphoma; multiple myeloma; and
non-Hodgkin's lymphoma. ...
Centre Daily Times
October 28, 2008
InNexus has launched into pre-clinical development its first four products, DXL625 and DXLr120, both for the prospective treatment of non-Hodgkin's lymphoma ...
DG News
October 28, 2008
... multiple myeloma, chronic lymphocytic leukaemia, acute myeloid leukaemia, acute lymphocytic leukaemia,
Hodgkin's lymphoma and
non-Hodgkin's lymphoma. ...
7thSpace Interactive (press release)
October 28, 2008
There is growing epidemiologic evidence of an increased risk for non-Hodgkin's lymphoma (NHL) in the vicinity of some municipal solid waste incinerators ...
Science Daily (press release)
October 27, 2008
ScienceDaily (Oct. 27, 2008) - Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of ...
Curetoday.com (press release)
October 25, 2008
In the late 1960s, they cure patients with
Hodgkin's disease and
non-Hodgkin's lymphoma using
nitrogen mustard, vincristine, procarbazine, ...
Medical News Today (press release)
October 23, 2008
Socioeconomic factors such as income and
education appear to affect whether people with
non-Hodgkin lymphoma receive appropriate treatment, according to a ...
Scotsman
October 23, 2008
Nathan, who works with adults with learning difficulties, was diagnosed with lymphoblastic
lymphoma, a very rare form of
non-Hodgkin's lymphoma, ...
MarketWatch
October 23, 2008
Unlike many other approaches to treating non-Hodgkin's lymphoma, BiovaxID is designed to kill only cancerous B-cells, with the initial indication of ...
Kaiser network.org
October 23, 2008
Socioeconomic factors such as income and
education appear to affect whether people with
non-Hodgkin lymphoma receive appropriate treatment, according to a ...
News-Medical.net
October 23, 2008
Socioeconomic factors and the type of treatment received have an impact on a non-Hodgkin lymphoma (NHL) patient's risk of dying. ...
7thSpace Interactive (press release)
October 21, 2008
HIV-related neoplastic processes that affect the musculoskeletal system include Kaposi's sarcoma and
non-Hodgkin's lymphoma, the latter being mainly ...
Cancer Consultants
October 21, 2008
... have reported that Revlimid (lenalidomide) is active for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). ...
Ivanhoe
October 21, 2008
(Ivanhoe Newswire) -- A new study sheds light on factors that affect the outcome of patients with non-Hodgkin lymphoma. The study finds socioeconomic ...
